Oncology Institute, Inc. (TOI) Free Cash Flow (2020 - 2026)

Oncology Institute (TOI) has 7 years of Free Cash Flow data on file, last reported at -$2.2 million in Q1 2026.

• Quarterly Free Cash Flow rose 55.33% year-over-year to -$2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$25.0 million (down 31.65% YoY) and the FY2025 annual result came in at -$27.8 million, up 8.38% from the prior year.
• Free Cash Flow retreated to -$2.2 million in Q1 2026, from $30000.0 in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $813000.0 in Q3 2024 to a low of -$19.4 million in Q4 2022.
• A 5-year average of -$9.7 million and a median of -$11.1 million in 2025 frame the typical range for Free Cash Flow.
• Annual changes were most pronounced in 2022 — Free Cash Flow tumbled 4311.48% — and 2024, when it soared 109.78%.
• Tracing TOI's Free Cash Flow over 5 years: stood at -$19.4 million in 2022, then surged by 79.91% to -$3.9 million in 2023, then jumped by 106.11% to $238000.0 in 2024, then slumped by 87.39% to $30000.0 in 2025, then plunged by 7530.0% to -$2.2 million in 2026.
• The last three Free Cash Flow figures came in at -$2.2 million (Q1 2026), $30000.0 (Q4 2025), and -$11.1 million (Q3 2025), per Business Quant data.